FHIR
© HL7.org
|
Server Home |
FHIR Server FHIR Server 3.7.22-SNAPSHOT
|
FHIR Version n/a
User: [n/a]
FHIR
© HL7.org
|
Server Home |
FHIR Server FHIR Server 3.7.22-SNAPSHOT
|
FHIR Version n/a
User: [n/a]
Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2006. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 432694010 | Tyloxapol adverse reaction | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 687345018 | Tyloxapol adverse reaction (disorder) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 7375461000241114 | effet secondaire du tyloxapol | fr | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT Switzerland NRC maintained Module |
| 7375471000241118 | réaction indésirable au tyloxapol | fr | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT Switzerland NRC maintained Module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Tyloxapol adverse reaction | Is a | Mucolytics adverse reaction | false | Inferred relationship | Some | ||
| Tyloxapol adverse reaction | Causative agent (attribute) | Product containing tyloxapol (medicinal product) | false | Inferred relationship | Some | ||
| Tyloxapol adverse reaction | Causative agent (attribute) | Pharmaceutical / biologic product (product) | false | Inferred relationship | Some | ||
| Tyloxapol adverse reaction | Causative agent (attribute) | Tyloxapol (substance) | true | Inferred relationship | Some | 1 | |
| Tyloxapol adverse reaction | Causative agent (attribute) | Pharmaceutical / biologic product (product) | false | Inferred relationship | Some | ||
| Tyloxapol adverse reaction | Is a | All noxious and unintended responses to a medicinal product related to any dose should be considered adverse drug reactions (from US FDA Guideline for Industry, Clinical Safety Data Management: Definitions and Standards for Expedited Reporting). | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
This concept is not in any reference sets